Compounds for the treatment of disorders and salts and polymorphs thereof
OwnerDarren James Kelly, Michelle Papadimitriou +2inventors
InventorsDarren James Kelly, Michelle Papadimitriou, Chris Bums, Eric Daniels
Life of this patent
Estimating the term…
Abstract
Disclosed herein are salts of the compound of Formula (I) and polymorphs thereof, methods of making the same, and their methods of use in treating eye diseases and disorders, particularly those associated with inflammation and/or vascular proliferation in subjects. The methods include administering therapeutically effective amounts of salts of the compound of Formula (I) and polymorphic forms thereof, to a subject in need thereof.
Claims50
A crystalline form of a pharmaceutically acceptable salt of the compound of Formula (I):
A pharmaceutical composition comprising a crystalline form of any one of claims 1 to 16 and a pharmaceutically acceptable excipient.
The L-lysine salt of the compound of Formula (I):
The tert-butylamine salt of the compound of Formula (I):
Dependencies are inferred from the claim text.